France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
Category: Antibodies
Three Studies, One Result: Vaccines Point the Way Out of the Pandemic
New scientific research underscores the effectiveness of vaccines and their versatility in the fight against the coronavirus.
Pfizer and Moderna Vaccines Are Likely to Produce Long-Lasting Immunity, Study Suggests
Close examinations of more than a dozen vaccinated people found that immune cells were still organizing to fight the coronavirus months after inoculation.
Wondering if the Covid Vaccine Worked? Get the Right Test, at the Right Time
Scientists generally recommend against antibody testing after vaccination. But for some people, it makes sense.
Wondering if the Vaccine Worked? Get the Right Test, at the Right Time
Scientists generally recommend against antibody testing after vaccination. But for some people, it makes sense.
Scientists Report Earliest Known Coronavirus Cases in Five US States
Blood drawn from nine people in the earliest days of the pandemic tested positive for the infection. But some experts questioned the results.
Scientists Report Earliest Known Coronavirus Infections in Five U.S. States
Blood drawn from nine people in the earliest days of the pandemic tested positive for the infection. But some experts questioned the results.
Immunity to the Coronavirus May Persist for Years, Scientists Find
Important immune cells survive in the bone marrow of people who were infected with the virus or were inoculated against it, new research suggests.
Vaccines Are Effective Against the New York Variant, Studies Find
The research adds to a growing number of findings suggesting the Pfizer and Moderna shots are protective against the variants identified so far.
Antibody rates among Black and Hispanic New Yorkers are double those of others, new estimates show.
A study found at least a third of Black and Hispanic New York City residents had antibodies after the first wave a year ago, but only 16 percent of white New Yorkers did.